Skip to main content
Explore URMC
URMC / Center for Health + Technology / Leadership + Faculty


Ray DorseyRay Dorsey, MD, MBA 
Director, Center for Health + Technology 
David M. Levy Professor of Neurology

Through novel applications of technology, he and his colleagues seek to enable anyone anywhere to receive care, participate in research, and benefit from therapeutic advances. Dr. Dorsey’s research has been published in leading medical, neurology, and economic journals and has been featured on National Public Radio and in The New York Times and The Wall Street Journal. Disclosures

Erika Augustine, MD, MS Erika Augustine
Associate Director, Center for Health + Technology 
A movement disorders-trained Child Neurologist, Dr. Augustine’s clinical research focuses on advancing therapeutic development and methodology for rare pediatric neurological disorders through interdisciplinary collaboration. Dr. Augustine currently leads clinical programs developing novel therapeutics for the neuronal ceroid lipofuscinoses and co-directs the University of Rochester Hereditary Ataxia Clinic.

Chad HeatwoleChad Heatwole, MD, MS-CI 
Associate Director, Center for Health + Technology 
A neurologist with sub-specialty training in neuromuscular medicine, electrophysiology, and experimental therapeutic development, Dr. Heatwole’s main research focus is the development, evaluation, and testing of novel experimental therapeutics for neuromuscular disease. Under Dr. Healwole’s leadership, the first/founding institute for outcome measurement for neuromuscular disorders was established at the University of Rochester.

Cynthia CasaceliCynthia Casaceli, MBA 
Director, Clinical Trial Coordination Center 
Ms. Casaceli leads the University of Rochester’s Clinical Trial Coordination Center and has over 20 years of experience in the operational (project, data and central management) and administrative (contracts, budgets) conduct of an academic research organization.  Ms. Casaceli has overseen the conduct and compliance of clinical trials that have led to the FDA approval of seven compounds. 

Cornelia KampCornelia Kamp, MBA 
Executive Director Strategic Initiatives, Clinical Materials Services Unit 
Ms. Kamp has over 20 years of experience in pharmaceutical based research, both commercial and academic. She established and leads the Clinical Materials Services Unit (CMSU) which provides packaging, labeling, distribution, and return/destructions services for investigational drugs/devices. Ms. Kamp’s research interests include clinical trial design, regulatory aspects of conducting international clinical trials, recruitment strategies, and site performance metrics. 

Elise KaysonElise Kayson, MS, RNC, ANP 
Director, Clinical and Strategic Initiatives 
With over 20 years of experience, Ms. Kayson has led and managed over 50 clinical trials operationally and administratively for Huntington disease, Parkinson disease, and other rare disorders. She played a key role in the pivotal trials that resulted in the only two FDA approved drugs for Huntington disease. Ms. Kayson is a nurse practitioner and received her degrees in nursing from Alfred University and the University of Rochester. In 2016, she was recognized with a Lifetime Achievement Award from the Huntington Study Group.

Laura TrussoLaura Trusso, MS 
Director, Clinical Innovation 
Ms. Trusso joined CHeT/CTCC in October 2015 and has over 30 years of combined pre-clinical and clinical trials experience within the Pharmaceutical, Diagnostics and CRO industries. She has held multiple leadership roles throughout her career and played a key role in the approval of five pharmaceutical products and an in vitro diagnostic test for Hepatitis B. Ms. Trusso holds an MS in Environmental Toxicology.

Renee WilsonRenee Wilson, MA 
Director, Project Management 
Ms. Wilson has worked in the healthcare field for over 20 years, having been engaged in clinical care and research in the fields of neurology, psychiatry and bioethics. She has held various positions in clinical research for the past 15 years, and for the last 10 years has been managing multi-center clinical trials at the Clinical Trials Coordination Center. Ms. Wilson assumed the role of Director of Project Management in 2019 and holds a MA in Psychology.

Christine BrowerChristine A. Brower, MBA 
Director, Data Management 
Ms. Brower is the Director of Data Management. She has 24 years’ experience in information technology, data management and programming from the Department of Biostatistics and Computational Biology. Ms. Brower has an undergraduate degree in BioMedical Computing, received her MPH in 2001 and is currently working toward her MBA. Ms. Brower currently serves on the Academic IT Research Committee and is a member of the Dell Workstation Customer Advisory Council. 

Michael LentineMichael Lentine, MBA 
Financial Controller 
Mr. Lentine joined CHeT in September 2017. He brings over eight years of experience in Finance and Administration at the University of Rochester Medical Center. In his role, Mr. Lentine provides financial oversight for CHeT, including the Center’s Clinical Trials Coordination Center (CTCC), and Clinical Materials Services Unit (CMSU). He develops project budgets, negotiates contracts, and plays a role in driving forward the Center’s strategic plan. Mr. Lentine holds an MBA from the University of Rochester’s Simon School of Business.

Karen RabinowitzKaren Rabinowitz, JD 
Associate Director, Collaborations 
Legal Counsel 

Ms. Rabinowitz provides legal counsel for CHeT, and for the Center’s Clinical Trials Coordination Center and Clinical Materials Services Unit. She prepares and negotiates contracts with clinical trial sponsors, drug vendors, and consultants, as well as reviews informed consents, conflict-of -interest, and other regulatory documentation for clinical trials. She also acts as liaison between CHeT and various other departments at the University of Rochester.